A2 Biotherapeutics - Raised $280M Funding from 13 investors

A2 Biotherapeutics - Raised $280M Funding From 13 Investors

3 weeks from now

Jan 30, 2025  · List of A2 Biotherapeutics's institutional investors. TCG, located in San Francisco (United States), made their first investment in A2 Biotherapeutics on Nov 05, 2019 in its Series …

tracxn.com

A2 Biotherapeutics - Company Profile - Tracxn

3 weeks from now

Jan 22, 2025  · A2 Biotherapeutics - Developer of antigen-specific therapy for cancer treatment. Raised a total funding of $280M over 5 rounds from 13 investors. Founded by Alexander …

tracxn.com

A2 Biotherapeutics Stock Price, Funding, Valuation, Revenue

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics has raised $270.5M over 4 rounds. A2 Biotherapeutics's latest funding round was a Series C - II for $80M on January 9, 2025. Date. Round. Amount. ... A2 …

cbinsights.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing company based in Agoura Hills, Calif. A2 Bio plans to direct the Series C …

yahoo.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

January 09, 2025 09:02 AM Eastern Standard Time. AGOURA HILLS, Calif.–(BUSINESS WIRE)–A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first …

intelligence360.news

Series C - A2 Biotherapeutics - 2025-01-09 - Crunchbase

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics raised $80000000 on 2025-01-09 in Series C. Search Crunchbase. Start Free Trial ... Edit Investors Section. Number of Investors 2. Investor Name …

crunchbase.com

Founder Lodge | A2 Biotherapeutics, Inc. Raises $80,000,000 At …

3 weeks from now

Jan 10, 2025  · A2 Biotherapeutics, Inc. raises $80,000,000 at Series C on 2025-01-10 in Biotechnology Research, industry founded/co-founded by Jim Robinson ... $1,378.27M Raised …

founderlodge.com

A2 Biotherapeutics Funding Round - Gaebler.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics Funding Round. On 1/9/2025, A2 Biotherapeutics secured $80 million in Series C funding from Samsara BioCapital and The Column Group. Transaction …

gaebler.com

A2 Bio Closes $80 Million Series C Financing Round

3 weeks from now

Jan 9, 2025  · Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a …

pacbiztimes.com

A2 Biotherapeutics Secures $80 Million For Innovative Cancer …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, Inc. (A2 Bio), a pioneering company in the field of cell therapies, recently announced the successful completion of an $80 million Series C financing round. This …

investorshangout.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

financialcontent.com

Revolutionizing Cancer Treatment: A2 Biotherapeutics Secures …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics is thrilled to announce a significant funding milestone of $80 million, a strategic investment that will expedite the company’s mission to revolutionize cancer …

leadsontrees.com

A2 Biotherapeutics: $80 Million (Series C) Raised For Advancing ...

3 weeks from now

A2 Biotherapeutics – a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to target tumor cells and protect normal cells selectively – announced the closing …

pulse2.com

A2 Biotherapeutics Completes $80M Series C - Vcnewsdaily.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today …

vcnewsdaily.com

Cell Therapy Startup A2 Biotherapeutics Nets $80M Series C

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics has raised $80 million to run three experimental CAR-T programs for solid tumor cancers. ... A2 Bio­ther­a­peu­tics has raised $80 mil­lion to run three …

endpts.com

A2 Biotherapeutics Raises $80M Series C Funding - Finsmes.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, an Agoura Hills, CA-based clinical-stage cell therapy company developing logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

finsmes.com